FrancophonIA/ELRC3.0 huggingface dataset:
English: - weakness, feel light-headed or dizzy or have difficulty breathing, as these may be signs of a serious allergic (anaphylactic) reaction - swelling of the face, lips, tongue and throat (Quincke's oedema) - flu-like symptoms and a rash on the face followed by an extended rash with a high temperature, increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell (eosinophilia) and enlarged lymph nodes (Drug Reaction with Eosinophilia and Systemic Symptoms [DRESS]) - symptoms such as low urine volume, tiredness, nausea, vomiting, confusion and swelling in the legs, ankles or feet, as this may be a sign of sudden decrease of kidney function - a skin rash which may form blisters and look like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge) (erythema multiforme) - a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (Stevens-Johnson syndrome) - a more severe form of rash causing skin peeling in more than 30% of the body surface (toxic epidermal necrolysis) - signs of serious mental changes or if someone around you notices signs of confusion, somnolence (sleepiness), amnesia (loss of memory), memory impairment (forgetfulness), abnormal behaviour or other neurological signs including involuntary or uncontrolled movements.
Croatian: - slabost, osjećaj ošamućenosti ili vrtoglavice ili poteškoće s disanjem, budući da to mogu biti znakovi ozbiljne alergične (anafilaktičke) reakcije - oticanje lica, usana, jezika i grla (Quinckeov edem) - simptome nalik gripi i osip na licu popraćen proširenim osipom s visokom tjelesnom temperaturom, povećane vrijednosti jetrenih enzima u krvnim testovima, povećanje posebne vrste bijelih krvnih stanica (eozinofilija) i povećane limfne čvorove (reakcija na lijek s eozinofilijom i sistemskim simptomima [DRESS]) - simptome kao što je smanjen volumen mokraće, umor, mučninu, povraćanje, smetenost i oticanje u nogama, gležnjevima ili stopalima jer to može biti znak naglog smanjenja bubrežne funkcije - kožni osip koji može tvoriti mjehure i izgledati poput malih meta (središnje tamne mrlje okružene svijetlim područjem, s tamnim prstenom oko ruba) (multiformni eritem) - rasprostranjeni osip s mjehurićima i kožom koja se ljušti, posebice oko usta, nosa, očiju i genitalija (Stevens-Johnsonov sindrom) - puno teži oblik osipa koji uzrokuje ljuštenje kože u više od 30 % površine tijela (toksična epidermalna nekroliza)
English: 72.2% of the levetiracetam treated patients and 45.2% of the patients on placebo had a 50% or greater decrease in the frequency of PGTC seizures per week.
Croatian: U 72,2% bolesnika liječenih levetiracetamom i 45,2% bolesnika koji su dobivali placebo primijećeno je 50 %-tno ili više smanjenje učestalosti PGTK napadaja tjedno.
English: - The other ingredients are: sodium acetate trihydrate, glacial acetic acid, sodium chloride, water for injection.
Croatian: - Pomoćne tvari su: natrijev acetat trihidrat, ledena acetatna kiselina, natrijev klorid, voda za injekcije.
English: Other ingredients include sodium acetate trihydrate, glacial acetic acid, sodium chloride, water for injection.
Croatian: Ostale pomoćne tvari su natrijev acetat trihidrat, ledena acetatna kiselina, natrijev klorid, voda za injekcije.
English: Prevalence is significantly higher in Japanese patients when compared to non-Japanese patients.
Croatian: Prevalencija je značajno veća u japanskih bolesnika u usporedbi s bolesnicima koji nisu japanskog podrijetla - šepanje ili poteškoće s hodom.
English: Adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy:
Croatian: Dodatna terapija u liječenju parcijalnih napadaja sa sekundarnom generalizacijom ili bez nje u odraslih, adolescenata i djece od navršene 4. godine životas epilepsijome.
English: Serum Creatinine (mg/dl) ks= 0.55 in Children to less than 13 years and in adolescent female; ks= 0.7 in adolescent male Dosing adjustment for children and adolescents patients weighing less than 50 kg with impaired renal function
Croatian: ks = 0,55 za djecu mlađu od 13 godina i za adolescente ženskog spola; ks = 0,7 za adolescente muškog spola
English: Medicinal product with particulate matter or discoloration should not be used.
Croatian: Lijek koji sadrži čestice ili je promijenio boju ne smije se upotrijebiti.
English: (1) A 15 mg/kg (0.15 ml/kg) loading dose is recommended on the first day of treatment with levetiracetam.
Croatian: (1) Prvog dana liječenja levetiracetamom preporučuje se udarna doza od 15 mg/kg (0,15 ml/kg).
English: The NOAEL was <200 mg/kg/day for the dams and 200 mg/kg/day for the fetuses (equal to the MRHD on a mg/m2 basis).
Croatian: NOAEL je za gravidne ženke iznosila <200 mg/kg/dan, a za fetuse 200 mg/kg/dan (što je jednako MRHD-u, Maximum Recommended Human Dose, izraženom u mg/m2).
English: 250 mg 2.5 ml (half 5 ml vial)
Croatian: 250 mg 2,5 ml (pola bočice od 5 ml)
English: Kubickiego 11 02-954 Warszawa Polska tel. +48 22 642 07 75
Croatian: 02-954 Warszawa Polska tel.
English: As in adults, there is no evidence of clinically significant medicinal product interactions in paediatric patients receiving up to 60 mg/kg/day levetiracetam.
Croatian: Kako ni u odraslih, tako ni u pedijatrijskih bolesnika koji su dobivali do 60 mg/kg/dan levetiracetama, nema dokaza o klinički značajnim interakcijama s lijekovima.
English: Volume of Diluent
Croatian: Volumen otopine za razrjeđivanje
English: Levetiracetam SUN is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy.
Croatian: Levetiracetam SUN je indiciran kao monoterapija u liječenju parcijalnih napadaja sa sekundarnom generalizacijom ili bez nje u odraslih i adolescenata od 16. godine života s novodijagnosticiranom epilepsijom.
English: Common: may affect up to 1 in 10 people - anorexia (loss of appetite) - depression, hostility or aggression, anxiety, insomnia, nervousness or irritability - convulsion, balance disorder (equilibrium disorder), dizziness (sensation of unsteadiness),
Croatian: Često: mogu se javiti u do 1 na 10 ljudi - anoreksija (gubitak apetita) - depresija, netrpeljivost ili agresivnost, tjeskoba, nesanica, nervoza ili razdražljivost - konvulzije, poremećaj ravnoteže, omaglica (osjećaj nestabilnosti), letargija (nedostatak energije i elana), tremor (nevoljno drhtanje) - vrtoglavica (osjećaj vrtnje) - kašalj - bol u trbuhu, proljev, dispepsija (probavne tegobe), povraćanje, mučnina - osip - astenija /umor (zamaranje)
English: Sodium acetate trihydrate Glacial acetic acid Sodium chloride Water for injection
Croatian: 6.1 Popis pomoćnih tvari natrijev acetat trihidrat acetatna kiselina, ledena natrijev klorid voda za injekcije
English: 1000 mg 10 ml (two 5 ml vials)
Croatian: 1000 mg 10 ml (dvije bočice od 5 ml)
English: Alopecia, eczema, Toxic epidermal
Croatian: Alopecija, ekcem, pruritis,
English: The NOAEL (No Observed Adverse Effect Level) was 3600 mg/kg/day for pregnant female rats (x 12 the MRHD on a mg/m2 basis) and 1200 mg/kg/day for fetuses.
Croatian: NOAEL (No Observed Adverse Effect Level, razina pri kojoj se ne uočava štetni učinak) za gravidne štakorice iznosila je 3600 mg/kg/dan, a za fetuse 1200 mg/kg/dan (12-erostruka vrijednost najveće preporučene doze za čovjeka izražena u mg/m2).
English: No adverse reactions on male or female fertility or reproduction performance were observed in rats at doses up to 1800 mg/kg/day (x 6 the MRHD on a mg/m2 or exposure basis) in parents and F1 generation.
Croatian: Kod mužjaka i ženki štakora roditeljske i F1 generacije nisu primijećeni štetni učinci na plodnost ili na reprodukciju u dozama do 1800 mg/kg/dan (6-erostruka vrijednost najveće preporučene doze za čovjeka izražena u mg/m2 ili na osnovnu izloženosti).
English: Levetiracetam SUN is for intravenous use.
Croatian: Levetiracetam SUN se daje u venu.
English: 10 to 20 mg/kg (0.10 to 0.20 ml/kg) once daily (1) (2)
Croatian: 10 do 20 mg/kg (0,10 do 0,20 ml/kg) jednaput na dan (1) (2)
English: undergoing dialysis (1) (1) A 750 mg loading dose is recommended on the first day of treatment with levetiracetam.
Croatian: (1) Prvog dana liječenja levetiracetamom preporučuje se udarna doza od 750 mg.
English: The active substance, levetiracetam, is a pyrrolidone derivative (S-enantiomer of α-ethyl-2-oxo-1-pyrrolidine acetamide), chemically unrelated to existing antiepileptic active substances.
Croatian: Farmakoterapijska skupina: antiepileptici, ostali antiepileptici, ATK oznaka: N03AX14 Djelatna tvar, levetiracetam, jest derivat pirolidona (S-enantiomer α-etil-2-okso-1-pirolidinacetamida), kemijski različit od postojećih antiepileptičkih djelatnih tvari.
English: Deutschland Sun Pharmaceuticals Germany GmbH
Croatian: Sun Pharmaceuticals Germany GmbH Hemmelrather Weg 201
English: Package Leaflet: Information for the patient Levetiracetam SUN 100 mg/ml concentrate for solution for infusion levetiracetam
Croatian: Uputa o lijeku: Informacija za bolesnika Levetiracetam SUN 100 mg/ml koncentrat za otopinu za infuziju levetiracetam
English: Levetiracetam SUN concentrate for solution for infusion can be used when administration of oral levetiracetam is temporarily impossible.
Croatian: Levetiracetam SUN koncentrat za otopinu za infuziju je druga mogućnost za bolesnike kada primjena levetiracetama kroz usta privremeno nije moguća.
English: Levetiracetam has been given to you by your doctor to reduce the number of fits - with other antiepileptic medicines (add-on therapy) to treat: partial onset seizures with or without generalisation in adults, adolescents and children from 4 years of age myoclonic seizures (short, shock-like jerks of a muscle or group of muscles) in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy primary generalised tonic-clonic seizures (major fits, including loss of consciousness) in adults and adolescents from 12 years of age with idiopathic generalised epilepsy (the type of epilepsy that is thought to have a genetic cause).
Croatian: - uz druge antiepileptike (kao dodatna terapija) u liječenju: parcijalnih napadaja sa sekundarnom generalizacijom ili bez nje u odraslih, adolescenata i djece od 4. godine života miokloničkih napadaja (kratki, iznenadni trzaji mišića ili skupine mišića) u odraslih i adolescenata starijih od 12. godine života s juvenilnom miokloničkom epilepsijom primarno generaliziranih toničko-kloničkih napadaja (veliki napadaji, dovode do gubitka svijesti) u odraslih i adolescenata starijih od 12. godine života s idiopatskom generaliziranom epilepsijom (oblik epilepsije za koju se smatra da je genetski uvjetovana).
English: Creatinine clearance Dose and frequency (ml/min/1.73 m2)
Croatian: Klirens kreatinina (ml/ min/1,73 m2)
English: The safety and efficacy of Levetiracetam SUN in children below and adolescents 16 years as monotherapy treatment have not been established.
Croatian: Kod monoterapije u djece i adolescenata mlađih od 16 godina sigurnost i djelotvornost Levetiracetam SUN-a nije dokazana.
English: Each 5 ml vial contains 500 mg of levetiracetam.
Croatian: Jedna bočica od 5 ml sadrži 500 mg levetiracetama.
English: End-stage renal disease patients -
Croatian: Bolesnici u završnoj fazi bubrežne bolesti na dijalizi
English: The intravenous formulation is an alternative to the oral formulation.
Croatian: Intravenski oblik lijeka predstavlja drugu mogućnost načina davanja od one koju ima oblik za primjenu kroz usta.
English: Choreoathetosis, dyskinesia, hyperkinesia, gait disturbance.
Croatian: Koreoatetoza, diskinezija, hiperkinezija, poremećaji hodanja, encefalopatija
English: The NOAEL was ≥ 1800 mg/kg/day for the F0 females, and for the survival, growth and development of the F1 offspring up to weaning.
Croatian: NOAEL je iznosila ≥ 1800 mg/kg/dan za F0 ženke, te za preživljenje, rast i razvoj za F1 potomstvo do odbića (6-erostruka vrijednost najveće preporučene doze za čovjeka izražena u mg/m2).
English: Each vial contains 19 mg of sodium For the full list of excipients, see section 6.1.
Croatian: Za cjeloviti popis pomoćnih tvari, vidjeti dio 6.1.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Levetiracetam SUN 100 mg/ml sterile concentrate levetiracetam
Croatian: NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA Levetiracetam SUN 100 mg/ml sterilni koncentrat levetiracetam i.v.
English: 15 minutes Twice daily 3000 mg/day
Croatian: 15 minuta Dva puta na dan 3000 mg/dan
English: 15 minutes Twice daily 500 mg/day
Croatian: 15 minuta Dva puta na dan 500 mg/dan
English: NAME OF THE MEDICINAL PRODUCT Levetiracetam SUN 100 mg/ml concentrate for solution for infusion
Croatian: NAZIV GOTOVOG LIJEKA Levetiracetam SUN 100 mg/ml koncentrat za otopinu za infuziju
English: CLcr (ml/min) = -------------------------------------- (x 0.85 for women)
Croatian: [140 - dob (godine)] x težina (kg) CLcr (ml/min) = --------------------------------------------- (x 0,85 za žene) 72 x kreatinin u serumu (mg/dl)
English: To be taken into consideration by patients on a controlled sodium diet.
Croatian: Bolesnici na dijeti s ograničenim unosom natrija trebaju to uzeti u obzir.
English: (impaired coordinated movements), paraesthesia (tingling), disturbance in attention (loss of concentration) - diplopia (double vision), vision blurred - elevated/abnormal values in a liver function test - hair loss, eczema, pruritus - muscle weakness, myalgia (muscle pain) - injury
Croatian: halucinacije, srditost, smetenost, napadaj panike, emocionalna nestabilnost/promjene raspoloženja, uznemirenost - amnezija (gubitak pamćenja), smetnje pamćenja (zaboravljivost), poremećaj koordinacije/ataksija (poremećaj koordinacije pokreta), parestezije (trnci), smetnje u koncentraciji (gubitak koncentracije) - diplopija (dvoslike), zamagljen vid - povišene/promijenjene vrijednosti testova jetrene funkcije - gubitak kose, ekcem, svrbež - slabost mišića, mijalgija (bol u mišićima) - ozljeda
English: Levetiracetam is excreted in human breast milk.
Croatian: Levetiracetam se izlučuje u majčino mlijeko u ljudi pa se dojenje ne preporučuje.
English: 15 minutes Twice daily 2000 mg/day
Croatian: 15 minuta Dva puta na dan 2000 mg/dan
English: Dose Withdrawal Volume
Croatian: Doza Volumen koji se treba izvući iz bočice
English: Rare: may affect up to 1 in 1,000 people - infection - decreased number of all blood cell types - severe allergic reactions (DRESS, anaphylactic reaction [severe and important allergic reaction], Quincke's oedema [swelling of the face, lips, tongue and throat])) - decreased blood sodium concentration - suicide, personality disorders (behavioural problems), thinking abnormal (slow thinking, unable to concentrate) - delirium - encephalopathy (see sub-section “Tell your doctor immediately” for a detailed description of symptoms) - uncontrollable muscle spasms affecting the head, torso and limbs, difficulty in controlling movements, hyperkinesia (hyperactivity) - pancreatitis - liver failure, hepatitis - sudden decrease in kidney function - skin rash, which may form blisters and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge) (erythema multiforme), a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (StevensJohnson syndrome), and a more severe form causing skin peeling in more than 30% of the body surface (toxic epidermal necrolysis) rhabdomyolysis (breakdown of muscle tissue) and associated blood creatine phosphokinase increase.
Croatian: angioedem [oticanje lica, usana, jezika i grla]) - snižena koncentracija natrija u krvi - samoubojstvo, poremećaj osobnosti (problemi u ponašanju), poremećaj mišljenja (sporo razmišljanje, nemogućnost koncentriranja) - delirij - oštećenje mozga (encefalopatija, za detaljan opis simptoma pogledajte podnaslov (vidjeti pododjeljak „Recite odmah svom liječniku“ za detaljni opis simptoma) - nekontrolirani mišićni grčevi koji zahvaćaju glavu, trup i udove, teškoće u kontroliranju pokreta, hiperkinezija (hiperaktivnost) - upala gušterače - zatajenje jetre, hepatitis - iznenadno smanjenje bubrežne funkcije
English: Levetiracetam SUN is not indicated in children and adolescents below 16 years on its own (monotherapy).
Croatian: Djeca i adolescenti - U djece i adolescenata mlađih od 16 godina Levetiracetam SUN se ne primjenjuje samostalno
English: 15 minutes Twice daily 1000 mg/day
Croatian: 15 minuta Dva puta na dan 1000 mg/dan
English: Detailed information on this medicine is available on the European Medicines Agency web site:
Croatian: Detaljnije informacije o ovom lijeku dostupne su na internetskim stranicama Europske agencije za lijekove http://www.ema.europa.eu
English: Levetiracetam SUN may impair your ability to drive or operate any tools or machinery, as it may make you feel sleepy.
Croatian: Ako vozite ili upravljate alatima ili vozilima potreban je oprez jer se pri uzimanju Levetiracetam SUN-a može javiti osjećaj pospanosti.
English: Intravenous use.
Croatian: Za primjenu u venu
English: NAME OF THE MEDICINAL PRODUCT Levetiracetam SUN 100 mg/ml concentrate for solution for infusion levetiracetam
Croatian: Levetiracetam SUN 100 mg/ml koncentrat za otopinu za infuziju levetiracetam
English: Table 1.
Croatian: Kubickiego 11
English: B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE Medicinal product subject to medical prescription.
Croatian: PRILOG II A. PROIZVOĐAČ ODGOVORAN ZA PUŠTANJE SERIJE LIJEKA U PROMET B. UVJETI ILI OGRANIČENJA VEZANI UZ OPSKRBU I PRIMJENU C. OSTALI UVJETI I ZAHTJEVI ODOBRENJA ZA STAVLJANJE GOTOVOG LIJEKA U PROMET D. UVJETI ILI OGRANIČENJA VEZANI UZ SIGURNU I UČINKOVITU PRIMJENU LIJEKA
English: STATEMENT OF ACTIVE SUBSTANCE(S) One vial contains 500 mg/5 ml levetiracetam.
Croatian: TVARI Jedna bočica sadrži 500 mg/5 ml levetiracetama.
English: Wash hands after handling the product.
Croatian: Oprati ruke nakon rukovanja proizvodom.
English: ATCvet code: QP53BE04
Croatian: ATCvet kod: QP53BE04
English: These signs typically resolve without treatment.
Croatian: Ovi znakovi obično prolaze bez liječenja.
English: Food enhances the absorption.
Croatian: Hrana potiče apsorpciju.
English: The terminal half-life is approximately 4 weeks.
Croatian: Terminalni poluživot iznosi oko 4 tjedna.
English: Due to insufficient data to support efficacy against ticks in young cats, this product is not recommended for the treatment of ticks in kittens 5 months of age or younger.
Croatian: Uslijed nedostatnih podataka za potporu učinkovitosti protiv krpelja kod mladih mačaka, ovaj se proizvod ne preporučuje za liječenje protiv krpelja kod mačića starosti 5 mjeseci ili mlađih.
English: 10 DATE OF REVISION OF THE TEXT <{DD/MM/YYYY}>
Croatian: DATUM REVIZIJE TEKSTA <{DD/MM/GGGG}>
English: Each chewable tablet contains:
Croatian: Svaka tableta za žvakanje sadržava:
English: Crospovidone
Croatian: Krospovidon
English: Administer with or after food.
Croatian: Primijeniti uz ili nakon obroka.
English: 1 tablet 3 tablets 6 tablets
Croatian: 1 tableta 3 tablete
English: Lotilaner is approximately 10 times more bioavailable when administered with food.
Croatian: Lotilaner ima otprilike 10 puta veću bioraspoloživost kad se primjenjuje uz obrok.
English: Appropriate combination of tablets
Croatian: Odgovarajuća kombinacija tableta
English: Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.
Croatian: Buhe i krpelji se moraju pričvrstiti na domaćina i započeti hranjenje, kako bi mogli biti izloženi djelatnoj tvari.
English: The terminal half-life is approximately 4 weeks (harmonic mean).
Croatian: Terminalni poluživot iznosi oko 4 tjedna (harmonijska sredina).
English: The major route of elimination is biliary excretion, and renal excretion is the minor route of elimination (less than 10 % of the dose).
Croatian: Glavni put eliminacije je izlučivanje putem žuč, a izlučivanje putem bubrega manje je zastupljeni put eliminacije (manje od 10% doze).
English: Body weight of dog (kg)
Croatian: Tjelesna težina psa (kg)
English: Parasites need to start feeding on the host to become exposed to lotilaner; therefore the risk of the transmission of parasite borne diseases cannot be completely excluded.
Croatian: Paraziti moraju započeti hranjenje na domaćinu kako bi bili izloženi lotilaneru; zato se rizik od zaraznih bolesti koje prenose paraziti ne može isključiti.
English: Body weight of cat (kg)
Croatian: Tjelesna težina mačke (kg)
English: Strength and number of tablets to be administered
Croatian: Jačina i broj tableta koje treba davati
English: For optimal control of tick and flea infestations, the veterinary medicinal product should be administered at monthly intervals and continued throughout the flea and/or tick season based on local epidemiological situations.
Croatian: Za optimalnu kontrolu infestacija krpeljima i buhama, veterinarsko-medicinski proizvod treba primjenjivati u mjesečnim intervalima i nastaviti tijekom sezone buha i/ili krpelja na temelju lokalne epidemiološke situacije.
English: Do not use this veterinary medicinal product after the expiry date which is stated on the carton box and blister after EXP.
Croatian: Ne koristite veterinarsko-medicinski proizvod poslije isteka roka valjanosti naznačenog na kartonskoj kutiji i blisteru poslije EXP.
English: Elanco France S.A.S 26 Rue de la Chapelle 68330 Huningue FRANCE
Croatian: Elanco France S.A.S. 26 Rue de la Chapelle 68330 Huningue FRANCUSKA
English: Blisters (dogs)
Croatian: Blisteri (mačke)
English: The periodic safety update report (PSUR) cycle should be restarted for submission of 6 monthly reports (covering all authorised presentations of the product) for the next two years, followed by yearly reports for the subsequent two years and thereafter at 3 yearly intervals.
Croatian: (pokrivajući sva odobrena pakovanja proizvoda), u naredne dvije godine, nakon kojih slijede godišnja izvješća za sljedeće dvije godine, a nakon toga u trogodišnjim intervalima.
English: Credelio 900 mg chewable tablets for dogs: 2 years
Croatian: Credelio 900 mg tablete za žvakanje za pse: 2 godine
English: 56 mg lotilaner 112 mg lotilaner 225 mg lotilaner 450 mg lotilaner 900 mg lotilaner
Croatian: lotilaner 56 mg lotilaner 112 mg lotilaner 225 mg lotilaner 450 mg lotilaner 900 mg
English: Credelio 56 mg, 112 mg, 225 mg, 450 mg chewable tablets for dogs: 3 years
Croatian: Credelio 56 mg, 112 mg, 225 mg, 450 mg tablete za žvakanje za pse: 3 godine
English: Lotilaner is a potent inhibitor of gamma-aminobutyric acid (GABA)-gated chloride channels, resulting in rapid death of ticks and fleas.
Croatian: Lotilaner je jak inhibitor kloridnih kanala reguliranih gama-aminomaslačnom kiselinom (GABA), što izaziva brzo ugibanje krpelja i buha.
English: Credelio chewable tablets lotilaner (mg)
Croatian: Credelio tablete za žvakanje lotilaner (mg)
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Credelio 12 mg (0.5-2.0 kg)
Croatian: NAZIV VETERINARSKO-MEDICINSKOG PROIZVODA Credelio 12 mg (0,5-2,0 kg)
English: Therefore, the product breaks the flea life cycle and prevents environmental flea contamination in areas to which the cat has access.
Croatian: Dakle, proizvod prekida životni ciklus buha i sprječava kontaminaciju buhama, područja u koja mačka ima pristup.
English: This long terminal half-life provides effective blood concentrations for the entire duration of the interdosing interval.
Croatian: Tako dugi terminalni poluživot omogućuje djelotvornu koncentraciju u krvi tijekom cijelog razdoblja između dva doziranja.
English: The veterinary medicinal product kills existing and newly emerged fleas on cats before they can lay eggs.
Croatian: Veterinarsko-medicinski proizvod ubija buhe koje se već nalaze na mačkama i nove buhe prije nego stignu položiti jajašca.
English: This terminal half-life provides effective blood concentrations for the entire duration of the inter-dosing interval.
Croatian: Takav terminalni poluživot omogućuje djelotvornu koncentraciju u krvi tijekom cijelog razdoblja između dva doziranja.
English: MARKETING AUTHORISATION NUMBER(S) EU/2/17/206/016-21
Croatian: BROJ(EVI) ODOBRENJA ZA STAVLJANJE U PROMET EU/2/17/206/016-21